| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787927 | Journal of Thoracic Oncology | 2017 | 9 Pages |
Abstract
The MTD of a SBRT boost combined with 44 Gy of thoracic chemoradiation was 6 Gy à 5. A SBRT boost dose of 10 Gy à 2 could be considered safer, with no grade 3 or higher toxicities observed at this dose level during the follow-up period in this study.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kristin A. MD, Rathi N. MD, Zhengjia PhD, Sibo MD, Chao PhD, Pretesh MD, Suchita MD, Jay MD, Seth D. MD, Felix G. MD, Conor E. MD, Taofeek K. MD, PhD, Suresh S. MD, Jeffrey D. MD, Walter J. MD,